−0.3950SEK
−31.35 MSEK
About ARCEDE PHARMA AB
Sector
CEO
Erik Magnusson
Website
Headquarters
Lund
Founded
2003
ISIN
SE0018168742
FIGI
BBG0184D9VW5
Arcede Pharma AB operates as a drug development company. It develops drug candidates to treat chronic obstructive pulmonary disease and severe asthma. The company's drug candidates include RESP3000, RESP9000, and RESP1000. The company was founded on October 21, 2003 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ARCEDE is 0.0970 SEK — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ARCEDE PHARMA AB stocks are traded under the ticker ARCEDE.
ARCEDE stock is 11.63% volatile and has beta coefficient of 1.68. Check out the list of the most volatile stocks — is ARCEDE PHARMA AB there?
Yes, you can track ARCEDE PHARMA AB financials in yearly and quarterly reports right on TradingView.
ARCEDE stock has fallen by 9.58% compared to the previous week, the month change is a 2.80% fall, over the last year ARCEDE PHARMA AB has showed a 95.79% decrease.
ARCEDE net income for the last quarter is −24.25 M SEK, while the quarter before that showed −1.58 M SEK of net income which accounts for −1.44 K% change. Track more ARCEDE PHARMA AB financial stats to get the full picture.
No, ARCEDE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARCEDE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCEDE PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCEDE PHARMA AB technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCEDE PHARMA AB stock shows the neutral signal. See more of ARCEDE PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.